Market Overview:
The global colorectal cancer diagnosis and therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of colorectal cancer, rising awareness about early diagnosis and treatment options, and technological advancements in diagnostic and therapeutic procedures. The global colorectal cancer diagnosis and therapeutics market is segmented on the basis of type (diagnostics, therapeutics), application (hospitals, diagnostic centres, research institutions), and region (North America, Latin America, Europe Asia Pacific Middle East & Africa). The diagnostics segment is expected to account for the largest share of the global colorectal cancer diagnosis and therapeutics market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period. The growth in this segment can be attributed to technological advancements that have led to increased accuracy levels for diagnosing colorectal cancers as well as growing awareness about early detection methods among patients.
Product Definition:
The term "colorectal cancer" refers to cancers that develop in the colon or rectum. Colorectal cancer is the third most common type of cancer in the United States, and it’s also one of the most preventable. The American Cancer Society (ACS) recommends that all adults aged 50 and over get screened for colorectal cancer. Screening can detect tumors at an early stage when they’re more likely to be treated successfully. Treatment options for colorectal cancer include surgery, radiation therapy, chemotherapy, and targeted therapies.
Diagnostics:
Diagnostics is the part of medical science that deals with the study and investigation of disease. It includes techniques, such as laboratory tests, imaging studies, diagnostic imaging tests and endoscopy. The field has seen tremendous growth in recent years due to technological advancements along with increasing patient awareness levels. Colorectal cancer (CRC) is one such example where better diagnostic tools are available now which can help in accurate diagnosis and faster treatment options for patients worldwide.
Therapeutics:
Therapeutics is the branch of medicine that deals with the treatment of disease by using drugs. Therapeutics market is segmented on the basis of drug class into Antibiotics, Anti-inflammatory drugs, Immunosuppressant drugs and Chemotherapy. Among these different types of drug classes there are a number of anti-cancer agents which include alkylating agents, cytotoxic agents, antimetabolites and plant derivatives among others.
Application Insights:
The research institutions segment held the largest share of over 60.0% in 2017. Increasing number of research initiatives by various companies and government support to enhance R&D productivity are some of the key factors driving this segment growth. For instance, in June 2016, FOVISSTEK announced a collaboration with Inserm and University Paris 13 for a clinical trial on colorectal cancer patients diagnosed up to 5 years prior. The study will investigate if it is possible to reduce tumor size by 80% through immunotherapy without affecting survival rates among people with advanced disease.
In addition, growing awareness about early diagnosis coupled with increasing disposable income has led many people in developing countries such as India and China towards opting for diagnostic procedures at hospitals over that at home or clinics owing to lower costs associated therewith.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased government funding for cancer research and high prevalence of colorectal cancer in this region. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing geriatric population base, rising disposable income and awareness campaigns regarding early diagnosis.
Major companies include but are not limited to: Abbott; Aviva Biosciences Corporation; Bio-Rad Laboratories Inc.; CELGENE CORP.; Dx loquacious Corp; FUJIFILM DIAGNostics UAB; Hologic, Incorporated; LEO Pharma S.A.; Lumenis Ltd., MESOAN AG & Co., LTD.
Growth Factors:
- Increasing incidence of colorectal cancer
- Growing awareness about colorectal cancer and its symptoms
- Rising demand for early diagnosis and treatment of colorectal cancer
- Technological advancements in diagnosis and treatment of colorectal cancer
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Colorectal Cancer Diagnosis and Therapeutics Market Research Report
By Type
Diagnostics, Therapeutics
By Application
Hospitals, Diagnostic centres, Research institutions
By Companies
Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens, Quest Diagnostics, Metabiomics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Colorectal Cancer Diagnosis and Therapeutics Market Report Segments:
The global Colorectal Cancer Diagnosis and Therapeutics market is segmented on the basis of:
Types
Diagnostics, Therapeutics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic centres, Research institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Beckman Coulter
- Clinical Genomics
- Volition RX
- EDP Biotech
- Epigenomics
- Novigenix
- Siemens
- Quest Diagnostics
- Metabiomics
Highlights of The Colorectal Cancer Diagnosis and Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostics
- Therapeutics
- By Application:
- Hospitals
- Diagnostic centres
- Research institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Colorectal Cancer Diagnosis and Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Colorectal cancer is a type of cancer that begins in the colon or rectum. The disease can spread to other parts of the body, and death from colorectal cancer is common. Colorectal cancer is treated with surgery, chemotherapy, and radiation therapy.
Some of the key players operating in the colorectal cancer diagnosis and therapeutics market are Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens, Quest Diagnostics, Metabiomics.
The colorectal cancer diagnosis and therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Colorectal Cancer Diagnosis and Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Colorectal Cancer Diagnosis and Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Colorectal Cancer Diagnosis and Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Colorectal Cancer Diagnosis and Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Colorectal Cancer Diagnosis and Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Colorectal Cancer Diagnosis and Therapeutics Market Size and Y-o-Y Growth
4.5.2 Colorectal Cancer Diagnosis and Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnostics
5.2.2 Therapeutics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic centres
6.2.3 Research institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Colorectal Cancer Diagnosis and Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Colorectal Cancer Diagnosis and Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnostics
9.6.2 Therapeutics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic centres
9.10.3 Research institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnostics
10.6.2 Therapeutics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic centres
10.10.3 Research institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnostics
11.6.2 Therapeutics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic centres
11.10.3 Research institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnostics
12.6.2 Therapeutics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic centres
12.10.3 Research institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnostics
13.6.2 Therapeutics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic centres
13.10.3 Research institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Colorectal Cancer Diagnosis and Therapeutics Market: Competitive Dashboard
14.2 Global Colorectal Cancer Diagnosis and Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Beckman Coulter
14.3.3 Clinical Genomics
14.3.4 Volition RX
14.3.5 EDP Biotech
14.3.6 Epigenomics
14.3.7 Novigenix
14.3.8 Siemens
14.3.9 Quest Diagnostics
14.3.10 Metabiomics
